Medicare Part B drugs: trends in spending and utilization, 2008-2021
- Collection:
- Health Policy and Services Research
- Series Title(s):
- ASPE issue brief and Inflation Reduction Act research series
- Author(s):
- Nguyen, Nuguyen X., author Olsen, T. Anders, author Sheingold, Steven, author De Lew, Nancy, author
- Contributor(s):
- United States. Department of Health and Human Services. Office of the Assistant Secretary for Planning and Evaluation, issuing body.
- Publication:
- Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, June 9, 2023
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Cost Control Drug Utilization -- statistics & numerical data Drug Utilization -- trends Health Expenditures -- statistics & numerical data Health Expenditures -- trends Medicare Part B -- economics United States United States.
- Genre(s):
- Technical Report
- Abstract:
- Over the 2008-2021 period, Medicare fee-for-service (FFS) Part B drug spending per enrollee grew on average at 9.2 percent annually. This spending growth was more than triple the rate in Part D (2.6 percent) and nearly 4 times as high as the rate of per capita annual prescription drug spending across all payers (2.4 percent).a The Inflation Reduction Act (IRA) includes several new provisions designed to address the rapid rate of increase in Part B drug spending and lower costs for Medicare enrollees.
- Copyright:
- The National Library of Medicine believes this item to be in the public domain. (More information)
- Extent:
- 1 online resource (1 PDF file (21 pages))
- Illustrations:
- Illustrations
- NLM Unique ID:
- 9918697331606676 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/9918697331606676